-
Medicaid patients facing serious or life-threatening illnesses incurred $6,900 less in hospital costs if they received palliative care, compared with a similar group of patients who received usual care, according to a new study.
-
The tap test has variable results as a tool to assess patients with a presumed diagnosis of normal pressure hydrocephalus.
-
In a restrospective review, rituximab appeared beneficial for patients with medication-resistant myasthenia gravis.
-
New recommendations for HPV vaccine; guidelines for treatment of essential tremor; updates on smoking cessation drugs; and FDA actions.
-
Forty-nine clinical centers and 18 positron emission tomography (PET) centers in the United States and Canada participated in a randomized, blinded-adjudication clinical treatment trial of 195 patients with symptomatic atherosclerotic internal carotid artery occlusion (AICAO) who also had hemodynamic cerebral ischemia identified by ipsilateral increased oxygen extraction fraction measured by PET.
-
-
Teriflunomide, an orally administered inhibitor of dihydro-orotate dehydrogenase, was found to be superior to placebo in reducing relapses in a 2-year, Phase 3 clinical trial in patients with multiple sclerosis.
-
Menstrually related migraine is difficult to treat and options are limited. Hormonal manipulation is controversial and unproven.
-
Surgical removal of brain metastases remains an important part of palliative therapy for metastatic cancer.
-
Extracorporeal membrane oxygenation is associated with a high mortality and a high incidence of neurological complications including stroke, subarachnoid hemorrhage, and brain death.
